NIH Schedules Secret Biomedical Grant Review
Published Date: 6/30/2026
Notice
Summary
The Center for Scientific Review is holding a private virtual meeting on July 17, 2026, to review important grant applications about biomedical data. This meeting is closed to protect secret ideas and personal info. Researchers applying for these grants should note the date, as decisions could impact future funding and projects.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Closed NIH Grant Review Meeting
If you are a researcher who applied for Biomedical Data Repositories and Knowledgebases grants, a closed virtual panel will review those applications on July 17, 2026 from 10:00 a.m. to 11:00 a.m. The meeting is closed to protect confidential trade secrets, patentable material, and personal information; decisions from this review could affect future funding and projects.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13204 — Proposed Collection; 30-Day Comment Request; NIH Information Collection Forms to Support the Genetic Testing Registry (OD)
The NIH wants your thoughts on updating forms that help track genetic tests in their registry. If you’re involved in genetic testing or research, these changes could affect how you share info. You’ve got until July 30, 2026, to send in your comments—no cost, just your voice to help make things smoother and smarter!
2026-12844 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings on July 17, 2026, to review important grant applications. These meetings protect private info and trade secrets while deciding which science projects get funding. Researchers applying for grants in brain injury, neurobehavior, nanotech, and heart/lung studies should note these review dates and prepare accordingly.
2026-12842 — Government Owned Inventions Available for License: Compositions and Methods for Producing Dendritic Cell-based Vaccines With Enhanced Efficacy
The National Cancer Institute has created a new way to make cancer vaccines stronger by using special omega-3 fats to boost immune cells called dendritic cells. This could help scientists and companies develop better cancer treatments that work more effectively. If you’re in biotech or medicine, now’s the time to team up or license this exciting technology and help bring improved vaccines to patients faster.
2026-12843 — Government Owned Inventions Available for License: C8166-45 Cell Line
The National Cancer Institute is offering a special human T-cell line called C8166-45 for licensing. This cell line helps scientists study viruses like HTLV-1 and HIV, which can cause serious diseases. Researchers and companies can now use this tool to develop better treatments, with licensing info available starting June 2026—no patents, just pure science power ready to roll!
2026-12585 — Submission for OMB Review; 30-Day Comment Request; Chimpanzee Research Use Form (Office of the Director)
The NIH wants to keep collecting info using the Chimpanzee Research Use Form and is asking the public to share thoughts by July 23, 2026. This form helps track how chimpanzees are used in research, affecting scientists and animal welfare groups. No big changes or costs are expected, just a smooth extension of the current form’s approval.
2026-12565 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for cool science projects. If you’re a researcher waiting on grants, these reviews shape the future of your funding and the science world!
Previous / Next Documents
Previous: 2026-13114 — Self-Regulatory Organizations; Texas Stock Exchange LLC; Order Declaring Effective a Minor Rule Violation Plan
The Texas Stock Exchange (TXSE) just got the green light to use a Minor Rule Violation Plan that lets them handle small rule breaks with fines up to $2,500 without rushing to report each one immediately. This means TXSE can now report these minor slip-ups to the SEC every three months instead of right away, making things smoother and faster for everyone involved. Traders and firms on TXSE should keep an eye on this new, quicker way of handling small rule issues starting now!
Next: 2026-13118 — Silicon Metal From Australia: Final Affirmative Determination of Sales at Less Than Fair Value
The U.S. Department of Commerce has decided that Australian silicon metal is being sold in the U.S. for less than its fair price. Starting June 30, 2026, this means importers might face extra duties to keep things fair for American businesses. This move helps protect U.S. companies from unfair competition and keeps the market balanced.